Back to
VICTORY CAPITAL MANAGEMENT INC
RETAShowing 0 of 20 quarters
Position history for
VICTORY CAPITAL MANAGEMENT INC's holdings in REATA PHARMACEUTICALS INC-A
As of its Q2 2023 13F, Victory Capital held 211,931 shares of RETA (Reata Pharmaceuticals), worth $21.6M. Victory Capital's 13F filings listed RETA from Q1 2023 to Q2 2023, 2 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of RETA: WELLINGTON MANAGEMENT GROUP LLP